Skip to main content

Peer Review reports

From: Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: a systematic review and meta-analysis

Original Submission
21 Mar 2023 Submitted Original manuscript
9 Mar 2024 Reviewed Reviewer Report
15 Jun 2024 Reviewed Reviewer Report
11 Jul 2024 Author responded Author comments - Hao Hu
Resubmission - Version 2
11 Jul 2024 Submitted Manuscript version 2
15 Jul 2024 Author responded Author comments - Hao Hu
Resubmission - Version 3
15 Jul 2024 Submitted Manuscript version 3
16 Jul 2024 Author responded Author comments - Hao Hu
Resubmission - Version 4
16 Jul 2024 Submitted Manuscript version 4
13 Aug 2024 Reviewed Reviewer Report
25 Aug 2024 Reviewed Reviewer Report
2 Sep 2024 Author responded Author comments - Hao Hu
Resubmission - Version 5
2 Sep 2024 Submitted Manuscript version 5
3 Sep 2024 Author responded Author comments - Hao Hu
Resubmission - Version 6
3 Sep 2024 Submitted Manuscript version 6
3 Sep 2024 Author responded Author comments - Hao Hu
Resubmission - Version 7
3 Sep 2024 Submitted Manuscript version 7
7 Sep 2024 Author responded Author comments - Hao Hu
Resubmission - Version 8
7 Sep 2024 Submitted Manuscript version 8
Publishing
10 Sep 2024 Editorially accepted
30 Sep 2024 Article published 10.1186/s12876-024-03414-5

You can find further information about peer review here.

Back to article page